Depo-Provera Injury Lawyers
Mazie Slater Katz & Freeman is currently investigating Depo-Provera claims. Depo-Provera (also known as medroxyprogesterone acetate) is used as method of birth control, as a part of menopausal hormone therapy, and to treat endometriosis, abnormal uterine bleeding, paraphilia, and certain types of cancer, including breast, kidney, and endometrial.
Based on our investigation, Depo-Provera can cause or promote meningioma tumors surrounding the brain and spinal cord. In March 2024, the British Medical Journal published a study finding that women who consistently received Depo-Provera had a 555% increased risk of developing intracranial meningiomas, especially after prolonged use. These tumors can exert pressure on the brain, causing a variety of symptoms, including the following:
- Persistent headaches: particularly worse in the morning,
- Seizures and balance issues,
- Vision changes: blurred or double vision,
- Hearing loss or tinnitus,
- Memory loss or confusion, and
- Weakness in limbs and trouble speaking.
Surgery may be required to remove these tumors and relieve these symptoms.
Importantly, the U.S. Depo-Provera label does not currently warn of these meningioma risks, but the European versions of the label do include such warnings.
Pfizer manufactures brand-named Depo-Provera, while several other companies sell a generic version of the medication.
Mazie Slater has led litigations against pharmaceutical and medical device companies on behalf of thousands of patients. If you or someone you know has a potential Depo-Provera claim, contact one of our qualified Depo-Provera attorneys today for a free consultation.
